- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.81 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x B97: (10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one(Non-covalent)
- 6 x CL: CHLORIDE ION(Non-functional Binders)
CL.2: 4 residues within 4Å:- Chain A: S.246, N.247, S.253, R.259
Ligand excluded by PLIPCL.5: 4 residues within 4Å:- Chain B: S.246, N.247, S.253, R.259
Ligand excluded by PLIPCL.8: 4 residues within 4Å:- Chain C: S.246, N.247, S.253, R.259
Ligand excluded by PLIPCL.11: 4 residues within 4Å:- Chain D: S.246, N.247, S.253, R.259
Ligand excluded by PLIPCL.14: 5 residues within 4Å:- Chain E: S.246, N.247, H.248, S.253, R.259
Ligand excluded by PLIPCL.17: 4 residues within 4Å:- Chain F: S.246, N.247, S.253, R.259
Ligand excluded by PLIP- 6 x MW8: 5-(4-bromophenyl)-~{N}-(4-piperazin-1-ylphenyl)-~{N}-(pyridin-2-ylmethyl)furan-2-carboxamide(Non-covalent)
MW8.3: 14 residues within 4Å:- Chain A: F.128, I.131, P.170, I.236, G.240, Y.241, P.242, Y.245, S.246, N.247, G.249, E.271
- Chain D: Y.209, Y.210
7 PLIP interactions:5 interactions with chain A, 2 interactions with chain D- Hydrophobic interactions: A:I.131, A:I.236, A:Y.241, A:P.242, A:Y.245, D:Y.209
- Hydrogen bonds: D:Y.209
MW8.6: 14 residues within 4Å:- Chain A: Y.209, Y.210
- Chain B: F.128, I.131, P.170, I.236, G.240, Y.241, P.242, Y.245, S.246, N.247, G.249, E.271
7 PLIP interactions:6 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:I.131, B:I.236, B:Y.241, B:P.242, B:Y.245, A:Y.209
- Hydrogen bonds: B:E.271
MW8.9: 10 residues within 4Å:- Chain C: F.128, Q.132, I.236, G.240, Y.241, P.242, Y.245, S.246, G.249, E.271
5 PLIP interactions:5 interactions with chain C- Hydrophobic interactions: C:I.236, C:I.236, C:Y.241, C:P.242, C:Y.245
MW8.12: 14 residues within 4Å:- Chain B: Y.209, Y.210
- Chain D: F.128, I.131, P.170, I.236, G.240, Y.241, P.242, Y.245, S.246, N.247, G.249, E.271
7 PLIP interactions:5 interactions with chain D, 2 interactions with chain B- Hydrophobic interactions: D:I.131, D:I.236, D:Y.241, D:P.242, D:Y.245, B:Y.209
- Hydrogen bonds: B:Y.209
MW8.15: 13 residues within 4Å:- Chain E: F.128, I.131, P.170, I.236, G.240, Y.241, P.242, Y.245, S.246, N.247, H.248, G.249, E.271
8 PLIP interactions:8 interactions with chain E- Hydrophobic interactions: E:I.131, E:I.236, E:I.236, E:Y.241, E:Y.241, E:P.242, E:Y.245
- Hydrogen bonds: E:E.271
MW8.18: 13 residues within 4Å:- Chain E: Y.209, Y.210
- Chain F: F.128, I.131, I.236, G.240, Y.241, P.242, Y.245, S.246, N.247, G.249, E.271
7 PLIP interactions:6 interactions with chain F, 1 interactions with chain E- Hydrophobic interactions: F:I.131, F:I.236, F:Y.241, F:P.242, F:Y.245, E:Y.209
- Hydrogen bonds: F:E.271
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Beaumont, E.J. et al., Crystal structure of MAPKAPK2 (MK2) complexed with PF-3644022 and 5-(4-bromophenyl)-N-[4-(1-piperazinyl)phenyl]-N-(2-pyridinylmethyl)-2-furancarboxamide. To Be Published
- Release Date
- 2021-05-12
- Peptides
- MAP kinase-activated protein kinase 2: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.81 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x B97: (10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one(Non-covalent)
- 6 x CL: CHLORIDE ION(Non-functional Binders)
- 6 x MW8: 5-(4-bromophenyl)-~{N}-(4-piperazin-1-ylphenyl)-~{N}-(pyridin-2-ylmethyl)furan-2-carboxamide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Beaumont, E.J. et al., Crystal structure of MAPKAPK2 (MK2) complexed with PF-3644022 and 5-(4-bromophenyl)-N-[4-(1-piperazinyl)phenyl]-N-(2-pyridinylmethyl)-2-furancarboxamide. To Be Published
- Release Date
- 2021-05-12
- Peptides
- MAP kinase-activated protein kinase 2: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F